Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Adherence Among Adults With Cystic Fibrosis Is Low: A Retrospective Analysis of the CFHealthHub Digital Learning Health System.
Hoo ZH, Totton N, Waterhouse S, Lewis J, Girling C, Bradburn M, Arden MA, Whelan P, Ainsworth J, Dawson S, Millward S, Barnett K, Dewar J, Barr HL, Saini G, Shepherd E, Carroll M, Allenby MI, Daniels TV, Nightingale JA, Lowther M, Carolan C, Clarke C, Szczepanski R, Hutchings M, Edenborough FP, Curley R, Wildman MJ. Hoo ZH, et al. Among authors: barr hl. Chest. 2021 Dec;160(6):2061-2065. doi: 10.1016/j.chest.2021.06.039. Epub 2021 Jun 26. Chest. 2021. PMID: 34186037 No abstract available.
Glutamine supplementation in cystic fibrosis: A randomized placebo-controlled trial.
Forrester DL, Knox AJ, Smyth AR, Barr HL, Simms R, Pacey SJ, Pavord ID, Honeybourne D, Dewar J, Clayton A, Fogarty AW. Forrester DL, et al. Among authors: barr hl. Pediatr Pulmonol. 2016 Mar;51(3):253-7. doi: 10.1002/ppul.23370. Epub 2015 Dec 27. Pediatr Pulmonol. 2016. PMID: 26709241 Clinical Trial.
Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study.
Barr HL, Halliday N, Barrett DA, Williams P, Forrester DL, Peckham D, Williams K, Smyth AR, Honeybourne D, L Whitehouse J, Nash EF, Dewar J, Clayton A, Knox AJ, Cámara M, Fogarty AW. Barr HL, et al. J Cyst Fibros. 2017 Mar;16(2):230-238. doi: 10.1016/j.jcf.2016.10.005. Epub 2016 Oct 20. J Cyst Fibros. 2017. PMID: 27773591 Free PMC article.
Weight gain during acute treatment of an initial pulmonary exacerbation is associated with a longer interval to the next exacerbation in adults with cystic fibrosis.
Barr HL, Cámara M, Barrett D, Williams P, Forrester D, Smyth A, Honeybourne D, Whitehouse J, Nash E, Dewar J, Knox A, Fogarty AW. Barr HL, et al. ERJ Open Res. 2017 Aug 25;3(3):00057-2017. doi: 10.1183/23120541.00057-2017. eCollection 2017 Jul. ERJ Open Res. 2017. PMID: 28852645 Free PMC article.
Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study; response to comments.
Barr HL, Halliday N, Barrett DA, Williams P, Forrester DL, Peckham D, Williams K, Smyth AR, Honeybourne D, Whitehouse JL, Nash EF, Dewar J, Clayton A, Knox AJ, Cámara M, Fogarty AW. Barr HL, et al. J Cyst Fibros. 2017 Nov;16(6):e21. doi: 10.1016/j.jcf.2017.09.008. Epub 2017 Oct 25. J Cyst Fibros. 2017. PMID: 29079141 Free article. No abstract available.
Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis.
Bevan A, Hoo ZH, Totton N, Girling C, Davids IR, Whelan P, Antrobus S, Ainsworth J, Buchan I, Anderson A, Bourke S, Doe S, Echevarria C, Taylor J, Bell NJ, Bateman K, Jones C, Moran P, Fitch G, Martin M, McGowan A, Morrow S, Seabridge H, Bush N, Daniels T, Lee K, Robson N, Shiferaw D, Sweis D, Thomas R, Faulkner J, Flight WG, Poole S, Warnock L, Allenby MI, Carroll M, Daniels TV, Dunn H, Nightingale JA, Shepherd E, Ohri C, Gadsby J, Range S, Tature D, Barr HL, Dawson S, Dewar J, Miller B, Saini G, Galey P, Johnson J, Pasteur MC, Derry D, Gledhill H, Lawson A, Thomas M, Waine D, Cunningham J, Damani A, Higton A, Orchard C, Carolan C, Tahir M, Plummer A, Hutchings M, Edenborough FP, Curley R, Wildman MJ. Bevan A, et al. Among authors: barr hl. J Cyst Fibros. 2022 Mar;21(2):323-331. doi: 10.1016/j.jcf.2021.09.007. Epub 2021 Sep 23. J Cyst Fibros. 2022. PMID: 34565705 Free article.
Corrigendum to "Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis" [J Cyst Fibros (2022), 21/2, 323-331].
Bevan A, Hoo ZH, Totton N, Girling C, Davids IR, Whelan P, Antrobus S, Ainsworth J, Buchan I, Anderson A, Bourke S, Doe S, Echevarria C, Taylor J, Bell NJ, Bateman K, Jones C, Moran P, Fitch G, Martin M, McGowan A, Morrow S, Seabridge H, Bush N, Daniels T, Lee K, Robson N, Shiferaw D, Sweis D, Thomas R, Faulkner J, Flight WG, Poole S, Warnock L, Allenby MI, Carroll M, Daniels TV, Dunn H, Nightingale JA, Shepherd E, Ohri C, Gadsby J, Range S, Tature D, Barr HL, Dawson S, Dewar J, Miller B, Saini G, Galey P, Johnson J, Pasteur MC, Derry D, Gledhill H, Lawson A, Thomas M, Waine D, Cunningham J, Damani A, Higton A, Orchard C, Carolan C, Tahir M, Plummer A, Hutchings M, Edenborough FP, Curley R, Wildman MJ. Bevan A, et al. Among authors: barr hl. J Cyst Fibros. 2022 Sep;21(5):893-897. doi: 10.1016/j.jcf.2022.07.011. Epub 2022 Jul 28. J Cyst Fibros. 2022. PMID: 35907767 No abstract available.
39 results